Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-12

Clinical Trial Update: Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluating etravirine in HIV-infected patients who require lipid-lowering therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intelence (Etravirine)

Snippet

Sponsor: Calmy Alexandra | Conditions: HIV Infection | Phase 3 | Status: COMPLETED